Related Experiment Video
Updated: Sep 16, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Agonist Binding Reshapes the Kinetic Landscape and Allosteric Communication of APLNR Toward Activation-Competent
Hong Dai1,2,3, Jun-Yao Zhu1,2,3, Bao-Dan Zhang1,2,3
1College of Agriculture and Biological Science, Dali University, Dali 671003, China.
Abstract:
APLNR is a therapeutically important G protein-coupled receptor (GPCR) implicated in cardiovascular and metabolic regulation; however, how agonist binding reorganizes receptor dynamics to promote signaling competence remains poorly understood. Here, we used the small-molecule agonist CMF-019 as a representative ligand and integrated Gaussian accelerated molecular dynamics (GaMD), Markov state models (MSMs), and neural relational inference (NRI) to characterize the conformational dynamics, kinetic organization, and allosteric communication of APLNR in apo and CMF-019-bound states. We found that CMF-019 binding altered structural flexibility in extracellular and intracellular regions while modifying collective motions within the transmembrane core, indicating a transition toward a more signaling-permissive dynamic state. MSM analyses further revealed that CMF-019 binding redistributed APLNR toward activation-related intermediate conformations and accelerated transitions among metastable states. Mechanistically, NRI uncovered extensive rewiring of the receptor communication network, in which CMF-019 binding strengthened transmembrane coupling and redirected signal propagation toward more convergent signaling routes linked to intracellular functional regions. Together, these findings suggest that CMF-019 promotes APLNR signaling competence through integrated kinetic and allosteric remodeling, revealing a dynamic mechanism by which an agonist can reorganize receptor communication prior to downstream coupling.
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Allosteric Regulation

